V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033504 | 210038143 | 1.85 | 75.5 | null | 2015-03-20 | 2015-04-17 | ALL Int Gde A/B DInt PhIV pt1 PAsp | null | N | 210037781 | ALL INTENSIFICATION |
| 210033505 | 210012879 | null | 95 | Palliative (P) | 2017-06-01 | 2017-06-01 | ALL Int Gde A/B DInt PhIV pt1 PAsp | 2 | null | 210037785 | ALL INTENSIFICATION |
| 210033506 | 210012888 | 1.71 | null | null | 2016-11-14 | 2016-11-14 | Mercaptopurine | 02 | N | 210037803 | MERCAPTOPURINE |
| 210033508 | 210012908 | 1.7 | 66 | Disease modification (D) | 2018-04-30 | 2018-05-01 | Mercaptopurine | N | N | 210037983 | MERCAPTOPURINE |
| 210033509 | 210031409 | 1.63 | 16.3 | Curative (C) | 2017-01-05 | 2017-01-15 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 210038006 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210033510 | 210012917 | null | 73.5 | Palliative (P) | 2017-12-19 | 2018-01-28 | CNS Low Grade Glioma Vinblastine | 2 | N | 210038029 | VINBLASTINE |
| 210033511 | 210022143 | 1.75 | 96 | null | 2018-02-19 | 2018-03-14 | Dasatinib | N | N | 210038057 | DASATINIB |
| 210033512 | 210012934 | 1.77 | 99 | null | 2018-07-02 | 2018-07-02 | RIALTO TRIAL | 02 | N | 210038119 | CARBOPLATIN + ETOPOSIDE |
| 210033513 | 210012936 | 1.67 | null | Palliative (P) | 2019-01-20 | 2019-01-20 | RIALTO TRIAL | N | N | 210038121 | RIALTO TRIAL |
| 210033514 | 210012939 | null | null | Palliative (P) | 2015-11-26 | 2016-05-01 | Bendamustine +/- Prednisolone | N | N | 210038126 | ERWINIA ASPARAGINASE |
| 210033515 | 210012944 | 1.6 | 53 | Not known (9) | 2017-12-06 | 2018-02-19 | Nelarabine | null | N | 210038157 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210033516 | 210022154 | 1.25 | 90.2 | Disease modification (D) | 2015-05-18 | 2015-05-23 | Inotuzumab Ozogamicin | 02 | null | 210038174 | PENTOSTATIN |
| 210033517 | 210012954 | null | 78.6 | Curative (C) | null | 2019-11-30 | LOMUSTINE + PROCARBAZINE | N | N | 210038187 | LOMUSTINE + PROCARBAZINE |
| 210033518 | 210012959 | null | 84.7 | Curative (C) | 2015-11-21 | 2015-12-25 | CYCLOPHOSPHAMIDE | Y | N | 210038211 | CYCLOPHOSPHAMIDE |
| 210033519 | 210012963 | 1.78 | 80 | null | 2013-09-23 | 2014-05-11 | LOMUSTINE + PROCARBAZINE | Y | N | 210038222 | LOMUSTINE + PROCARBAZINE |
| 210033520 | 210012965 | 1.72 | 80 | Curative (C) | null | 2015-01-17 | Erwinase (Erwinia Asparaginase) | Y | N | 210038232 | NELARABINE |
| 210033521 | 210027911 | 1.83 | null | Curative (C) | 2013-10-11 | 2013-10-17 | CARBOPLATIN + VINCRISTINE | N | null | 210038235 | CARBOPLATIN + VINCRISTINE |
| 210033522 | 210012969 | 1.79 | null | Curative (C) | 2018-09-03 | 2018-09-06 | Bendamustine +/- Prednisolone | Y | null | 210038239 | RIALTO TRIAL |
| 210033523 | 210012972 | null | 107 | Curative (C) | 2018-02-26 | 2018-02-26 | CNS Low Grade Glioma Vinblastine | Y | N | 210038248 | VINBLASTINE |
| 210033524 | 210012981 | 1.9 | 90.6 | Curative (C) | 2016-06-09 | 2016-07-29 | LOMUSTINE + PROCARBAZINE | N | N | 210038298 | LOMUSTINE + PROCARBAZINE |
| 210033525 | 210022173 | 1.57 | null | Curative (C) | 2014-04-19 | 2016-05-23 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 210038312 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033526 | 210022176 | null | 67.8 | Curative (C) | 2014-10-30 | 2015-04-16 | RIALTO TRIAL | Y | N | 210038316 | NELARABINE |
| 210033527 | 210012990 | 1.72 | 80.7 | Curative (C) | 2018-06-25 | 2018-09-20 | Cyclophosphamide+Fludara+TBI Allo | N | N | 210038321 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033528 | 210012993 | 0 | 80 | Curative (C) | 2019-02-13 | 2019-03-06 | Cladribine (subcut) 5 days | 2 | N | 210038332 | CLADRIBINE |
| 210033529 | 210013002 | 1.79 | null | null | 2013-11-29 | 2014-01-03 | CYCLOPHOSPHAMIDE | null | null | 210038363 | CYCLOPHOSPHAMIDE |
| 210033530 | 210013005 | 1.82 | 52.1 | Curative (C) | 2013-05-24 | 2013-09-06 | CVP R | null | N | 210038377 | CHOP |
| 210033531 | 210037461 | 1.8 | 80 | Curative (C) | 2014-06-09 | 2014-06-13 | Dasatinib | 02 | N | 210038409 | DASATINIB |
| 210033532 | 210022183 | 1.55 | null | null | 2018-04-15 | 2018-04-15 | Cyclophosphamide+Fludara+TBI Allo | 2 | N | 210038442 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210033533 | 210013012 | 1.47 | null | Not known (9) | 2014-01-07 | 2014-02-07 | PONATINIB | Y | N | 210038444 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210033534 | 210013016 | 1.65 | null | Curative (C) | 2015-06-12 | 2015-10-16 | Inotuzumab Ozogamicin | 02 | N | 210038456 | UKALL XII |
| 210033535 | 210013025 | null | 110 | Curative (C) | 2018-01-24 | 2018-04-19 | Cyclophosphamide + Vincristine | null | null | 210038500 | INOTUZUMAB OZOGAMICIN |
| 210033536 | 210022192 | 1.02 | null | Curative (C) | 2015-12-26 | 2019-01-05 | Nelarabine | N | N | 210038512 | NELARABINE |
| 210033537 | 210013036 | 1.54 | 64.9 | Disease modification (D) | 2018-01-29 | 2018-02-07 | PONATINIB | N | N | 210038553 | IDELALISIB |
| 210033538 | 210022197 | 1.83 | 80.7 | null | 2014-06-06 | 2014-06-09 | CLADRIBINE | null | N | 210038557 | CLADRIBINE |
| 210033539 | 210013042 | 0 | null | Palliative (P) | 2013-09-22 | 2013-11-10 | Methotrexate High Dose (3g/m2) | 02 | N | 210038560 | INOTUZUMAB OZOGAMICIN |
| 210033540 | 210013045 | null | null | Palliative (P) | 2017-04-30 | 2017-05-13 | Carboplatin + Etoposide IV 3 day | N | N | 210038567 | INOTUZUMAB OZOGAMICIN |
| 210033541 | 210013062 | 1.67 | 5.96 | Palliative (P) | null | 2017-09-20 | Nelarabine | N | N | 210038656 | PENTOSTATIN |
| 210033542 | 210022210 | 1.6 | null | Palliative (P) | null | 2016-12-25 | Vinblastine | N | N | 210038667 | VINBLASTINE |
| 210033543 | 210013067 | 1.65 | 12 | Palliative (P) | null | 2018-03-26 | Bendamustine +/- Prednisolone | N | N | 210038669 | UKALL XII |
| 210033544 | 210013078 | 1.61 | 73.7 | Palliative (P) | null | 2014-08-27 | IDELALISIB | null | null | 210038728 | RIALTO TRIAL |
| 210033545 | 210013080 | 1.75 | 65.8 | Disease modification (D) | 2016-11-11 | 2016-12-01 | BENDAMUSTINE | 2 | N | 210038740 | ERWINIA ASPARAGINASE |
| 210033546 | 210022224 | 0 | 79.6 | Palliative (P) | 2015-10-18 | 2015-10-26 | CNS Low Grade Glioma Vinblastine | N | N | 210038791 | VINBLASTINE |
| 210033547 | 210013096 | 0 | 41.2 | Palliative (P) | 2016-04-11 | 2016-09-11 | LOMUSTINE + PROCARBAZINE | N | Y | 210038811 | LOMUSTINE + PROCARBAZINE |
| 210033548 | 210013106 | 0 | null | Disease modification (D) | 2018-03-13 | 2018-03-15 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210038851 | CARBOPLATIN + VINCRISTINE |
| 210033549 | 210022229 | 1.85 | 79.2 | Curative (C) | 2017-01-08 | 2017-01-09 | CARBOPLATIN + VINCRISTINE | null | null | 210038868 | CARBOPLATIN + VINCRISTINE |
| 210033550 | 210013112 | null | 82.1 | Disease modification (D) | 2014-11-25 | 2014-12-23 | CNS LGG 2004 03 vinc weekly+ carbo | 01 | null | 210038885 | CARBOPLATIN + VINCRISTINE |
| 210033551 | 210013118 | 0 | 64.7 | Curative (C) | 2018-01-10 | 2018-02-23 | BENDAMUSTINE | N | N | 210038895 | CVP R |
| 210033552 | 210013122 | 1.69 | null | Disease modification (D) | 2014-09-16 | 2016-06-17 | IDELALISIB | N | N | 210038911 | IDELALISIB |
| 210033553 | 210013125 | 1.52 | null | Palliative (P) | 2019-01-19 | 2019-01-27 | Nelarabine | N | N | 210038930 | CHLORAMBUCIL + OFATUMUMAB |
| 210033554 | 210013128 | 1.77 | 54.5 | null | 2014-03-30 | 2014-04-01 | CNS Low Grade Glioma Vinblastine | N | N | 210038936 | VINBLASTINE |